A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1986
10/28/1986	US4619913 Treatments employing drug-containing matrices for introduction into cellular lesion areas
10/28/1986	CA1213220A1 Base salts of piroxicam deposited on a pharmaceutically-acceptable carrier
10/28/1986	CA1213215A1 Stabilization of influenza virus vaccine
10/23/1986	WO1986006100A1 Human anti-inflammatory phospholipase inhibitor protein
10/23/1986	WO1986005986A1 Process for preparing carcinostatic substance complex
10/23/1986	WO1986005977A1 Steroidal liposomes
10/22/1986	EP0198490A2 Ophthalmic solutions and methods for improving the comfort and safety of contact lenses
10/22/1986	EP0198431A2 A process for lubricating water-soluble vitamin powders
10/22/1986	EP0198388A2 Enterally effective biologically active peptide or protein composition, method for the production thereof, and a pharmaceutical composition containing same
10/22/1986	CN85103123A Process for preparing glycerol ether phosphatides
10/21/1986	US4618577 Human-human hybridoma, CLNH5
10/21/1986	US4618492 Crosslinking agents that permit controlled release of amino-group-containing substances under mildly acidic conditions
10/21/1986	US4618491 Wetted with hydrophilic liquid and in combination with water soluble polyvalent metal salt
10/21/1986	US4618490 Method of treatment of animal and human tissues damaged by burns and frank visible gangrene
10/15/1986	EP0197876A1 Therapeutical composition for use in dermatology containing imidazolidinyl urea as an active substance
10/15/1986	EP0197718A2 New medicaments for topical use
10/15/1986	EP0197571A2 Novel derivatives of gamma-cyclodextrin
10/15/1986	EP0197510A2 A surfactant composed of acylated collagen or acylated gelatin and a production process thereof
10/15/1986	EP0197506A2 A surfactant composed of acylated collagen or acylated gelatin and a production process thereof
10/15/1986	EP0197308A2 Composition and method for producing prolonged pain relief
10/14/1986	US4617298 Method and compositions for weight control
10/14/1986	US4617187 Therapeutic method for treating radiation ulcers
10/14/1986	US4617186 Cationic polymers
10/09/1986	WO1986005789A1 Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use
10/09/1986	WO1986005694A1 Composition for delivery of orally administered substances
10/08/1986	EP0196904A2 Perfluoropolyether compositions
10/08/1986	EP0196813A1 A process for the preparation of a free flowing, homogeneous, iodophor containing wound powder
10/08/1986	EP0196769A2 A novel transdermal pharmaceutical absorption dosage unit
10/08/1986	EP0196632A1 Composition for transdermal drug delivery
10/08/1986	EP0196546A2 Pharmaceutical tableting method
10/08/1986	EP0196434A1 Process for the preparation of a composition based on a divided substance with a slight hydrosolubility
10/07/1986	US4616083 Stable antibacterial lyophilizates
10/07/1986	US4616022 With monovalent metal or ammonium salt of lauryl sulfate
10/07/1986	US4616008 Antibacterial solid composition for oral administration
10/07/1986	US4615885 Pharmaceutical composition containing urokinase
10/07/1986	US4615881 Parenteral solution of microencapsulated drug in liquid carrier
10/07/1986	US4615697 Bioadhesive compositions and methods of treatment therewith
10/07/1986	CA1212497A1 Crosslinked .beta.-alanine, and its various uses
10/07/1986	CA1212328A1 Antimycotic agents with a high release of active compound, in the form of a solution and spray
10/07/1986	CA1212327A1 Antimycotic agent with a high release of active compound, in the form of a cream
10/07/1986	CA1212326A1 Liquid formulations of dihydropyridines, a process for their preparation, and their use in combating diseases
10/07/1986	CA1212324A1 Fat emulsion containing prostaglandin
10/07/1986	CA1212322A1 Pharmaceutical formulations
10/01/1986	EP0196203A2 Stable gamma interferon formulation
10/01/1986	EP0196085A2 Composition containing ubidecarenone with promoted absorption
10/01/1986	EP0196002A2 Tablet composition for drug combinations
10/01/1986	CN85109229A Improvements in or relating to dobutamine salts
09/1986
09/30/1986	US4614741 Injectable suspensions
09/30/1986	US4614730 Using phospholipids
09/30/1986	US4614650 Cytotoxic composition including at least an immunotoxine and an amine
09/30/1986	US4614622 Polyoxyalkylene ethers of glycerin or 1,2-propanediol, esterified with fatty acid and/or isostearic acid, their synthesis and use as thickening or solubilizing agents
09/30/1986	CA1211984A1 Method of inhibiting sweetness
09/25/1986	WO1986005519A1 Polynucleotide assay reagent and method
09/25/1986	WO1986005518A1 Stereoregular polynucleotide-binding polymers
09/24/1986	EP0195731A2 Sweeteners, process for sweetening various products and compositions containing such sweeteners
09/24/1986	EP0195643A2 Compositions and device for controlled transdermal penetration of topical and systematic agents
09/24/1986	EP0195605A2 Process of making gelled cellulose triacetate product and a product made thereby
09/24/1986	EP0195114A2 Stabilized injection compositions and their preparations
09/23/1986	US4613616 Polymeric iron chelators
09/23/1986	US4613591 Adminiculum for antitumor agents
09/23/1986	US4613588 Inhibits enkephalinase
09/23/1986	US4613500 Powdery pharmaceutical composition for nasal administration
09/23/1986	US4613497 Dry, water-foamable pharmaceutical compositions
09/23/1986	US4613496 Tuberculosis
09/23/1986	US4613459 Incusation of inducer t-cells, polypeptides
09/23/1986	CA1211712A1 Soft gelatine capsule
09/17/1986	EP0194880A2 Multivitamin preparation
09/17/1986	EP0194807A2 Hydrated adhesive gel and method for preparing the same
09/17/1986	EP0194336A2 Oral mobenzoxamine preparation
09/17/1986	CN86102388A Hydrated adhesive gel and method for preparing the same
09/17/1986	CN86101476A Preparation of a composition based on a finely divided active principle of low water solubility
09/17/1986	CN85108437A Synthetical resin products and manufacturing process
09/16/1986	US4612310 Oxicams
09/16/1986	US4612194 Anti-rheumatic agents and their use
09/16/1986	US4612192 Oil components for cosmetics and pharmaceuticals
09/16/1986	CA1211595A1 Transparent silicone emulsions
09/16/1986	CA1211462A1 Alkyl poly(oxyalkylene) esters of acrylate oligomers and copolymers thereof for thickening purposes
09/16/1986	CA1211372A1 Pharmacological compositions based on cisplatinum and method for obtaining same
09/15/1986	EP0179858A4 Antacid composition.
09/12/1986	WO1986005098A1 Immunotoxin and method of making
09/12/1986	WO1986005096A1 Protein absorption enhancing agents
09/12/1986	WO1986005095A1 t-PA COMPOSITION AND METHOD OF GETTING INTO BLOOD STREAM
09/10/1986	EP0193984A2 Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
09/10/1986	EP0193917A2 Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
09/10/1986	EP0193884A2 Dicyclohexylalkanes, their production, cosmetic and pharmaceutic preparations containing same, and their use as oil component
09/10/1986	CN85109451A Process of the preparation of basic formulations of quinolonecarboxylic acids
09/09/1986	US4611008 Preparation of nitroesters for coronary artery therapy
09/09/1986	US4610978 Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
09/09/1986	US4610962 Regenerated cellulose fibers, solution of anhydride homo- or copolymer
09/09/1986	US4610875 Medicaments with a high degree of solubility and method for their production
09/09/1986	CA1211049A1 Gelatine capsule
09/03/1986	EP0193471A1 Use of an anhydrous solution of hydrogen peroxide in cosmetic and therapeutic preparations
09/03/1986	EP0193372A2 Intranasally applicable powdery pharmaceutical composition
09/03/1986	EP0193287A2 Etoposide preparations
09/03/1986	EP0193164A2 Sustained-release pharmaceutical preparation which comprised 2-nitroxy-methyl-6-chloropyridine, process for its preparation and use thereof
09/03/1986	EP0193161A2 Antibody hybrid molecules and process for their preparation
09/03/1986	EP0192909A1 Process for obtaining pharmaceutical forms with sustained release
09/03/1986	EP0192667A1 Device for initiating reperfusion treatment when heart attack symptoms are present.
09/03/1986	EP0192660A1 Absorption enhancing agents.
09/03/1986	EP0192640A1 Sucralfate suspension.

1 ... 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 ... 1712